Newstral
Article
The Times of India on 2020-08-14 07:29
Oxford Covid vaccine: Phase 3 trials to end by Nov
Related news
- SII to start Phase II trials of Oxford Covid vaccineThe Times of India
- Oxford vaccine: 5 takeaways from phase I/II trialsThe Times of India
- COVID-19: DCGI nod to SII for phase 2 and 3 human clinical trials of Oxford vaccine candidateThe Hindu
- OOxford vaccine trials to resumeoxfordstudent.com
- COVAXIN, ZyCoV-D move to phase 2 trials; SII to begin testing for Oxford COVID-19 vaccine next weekherald.co.zw
- NU.S. FDA chief willing to approve a COVID-19 vaccine before Phase 3 trials endnationalpost.com
- Phase 1 trials of local vaccine completedHurriyet Daily News
- Nod to Serum Institute for trials of Oxford vaccineThe Times of India
- OOxford COVID-19 vaccine trials paused after participant illnessoxfordstudent.com
- Coronavirus | Oxford vaccine trials to resume in U.K.The Hindu
- Oxford vaccine offers hope, trials in India soonThe Times of India
- Oxford, AstraZeneca to resume COVID-19 vaccine trialsvanguardngr.com
- Testing times: More work needed on AstraZeneca/Oxford vaccine trialsThe Japan Times
- India Pauses Oxford-AstraZeneca’s Covid-19 Vaccine Trialstntribune.com
- Oxford launch 1st human vaccine trials for Nipah virusThe Times of India
- India readies 5 sites for Oxford vaccine trialsThe Times of India
- Volunteer involved in trials for Oxford University coronavirus vaccine diesirishpost.com
- Oxford vaccine shows 90% efficacy in Phase-3 trialThe Hindu
- Covid vaccine: Moderna phase III trials from July 27The Times of India
- CNN goes inside critical phase 3 trials of Russian vaccineCNN